Jacques Pierre Moreau
Direktor/Vorstandsmitglied bei Mulleris Therapeutics, Inc.
Profil
Jacques Pierre Moreau is the founder of Biomeasure, Inc. which was founded in 1976.
He is also the founder of ProteoThera, Inc. Dr. Moreau's current jobs include Director positions at Mulleris Therapeutics, Inc. and Chondiothera, Inc. Dr. Moreau's former jobs include Non-Executive Director at Dr. Reddy's Laboratories Ltd., Director at Tercica, Inc., Director at Phytomedics, Inc., and Chief Scientific Officer & Executive VP at Ipsen SA. Dr. Moreau received an undergraduate degree from the University of Orléans.
Aktive Positionen von Jacques Pierre Moreau
| Unternehmen | Position | Beginn |
|---|---|---|
| Mulleris Therapeutics, Inc. | Direktor/Vorstandsmitglied | - |
| Chondiothera, Inc. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Jacques Pierre Moreau
| Unternehmen | Position | Ende |
|---|---|---|
Tercica, Inc.
 Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Direktor/Vorstandsmitglied | 03.02.2014 |
Phytomedics, Inc.
 Phytomedics, Inc. Pharmaceuticals: OtherHealth Technology Phytomedics, Inc. discovers, develops, and manufactures botanical therapeutics using proprietary platform technologies. The company was founded in December 1996 by Ilya Raskin and is headquartered in Jamesburg, NJ. | Direktor/Vorstandsmitglied | 03.12.2012 |
ProteoThera, Inc.
 ProteoThera, Inc. Pharmaceuticals: MajorHealth Technology ProteoThera, Inc. is a biotechnology company that develops drug targeting technology. It offers transformative platform, a proprietary tissue matrix-binding protein fusion technology. The firm develops therapeutics to create a new paradigm in the treatment of auto inflammatory diseases and in tissue regeneration. The company was founded by Jacques P. Moreau, Parth Patwari, and Richard T. Lee and is headquartered in MA. | Gründer | - |
| IPSEN | Technik-/Wissenschafts-/F&E-Leiter | - |
Biomeasure, Inc.
 Biomeasure, Inc. Pharmaceuticals: MajorHealth Technology Part of Ipsen SA, Biomeasure, Inc. researches, develops, and manufactures peptides and toxins for treating various conditions. The company is based in Milford, MA. The company was founded by Jacques Pierre Moreau. | Vorstandsvorsitzender | - |
Ausbildung von Jacques Pierre Moreau
| University of Orléans | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| DR. REDDY'S LABORATORIES LIMITED | Health Technology |
| IPSEN | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Health Technology |
Phytomedics, Inc.
Phytomedics, Inc. Pharmaceuticals: OtherHealth Technology Phytomedics, Inc. discovers, develops, and manufactures botanical therapeutics using proprietary platform technologies. The company was founded in December 1996 by Ilya Raskin and is headquartered in Jamesburg, NJ. | Health Technology |
Biomeasure, Inc.
Biomeasure, Inc. Pharmaceuticals: MajorHealth Technology Part of Ipsen SA, Biomeasure, Inc. researches, develops, and manufactures peptides and toxins for treating various conditions. The company is based in Milford, MA. The company was founded by Jacques Pierre Moreau. | Health Technology |
| Mulleris Therapeutics, Inc. | |
| Chondiothera, Inc. | |
ProteoThera, Inc.
ProteoThera, Inc. Pharmaceuticals: MajorHealth Technology ProteoThera, Inc. is a biotechnology company that develops drug targeting technology. It offers transformative platform, a proprietary tissue matrix-binding protein fusion technology. The firm develops therapeutics to create a new paradigm in the treatment of auto inflammatory diseases and in tissue regeneration. The company was founded by Jacques P. Moreau, Parth Patwari, and Richard T. Lee and is headquartered in MA. | Health Technology |
